Literature DB >> 17767358

The role of leukotriene receptor signaling in inflammation and cancer.

Ramin Massoumi1, Anita Sjölander.   

Abstract

Leukotrienes (LTs) and prostaglandins (PGs) are metabolites of arachidonic acid that play major roles in various inflammatory conditions. The release of these mediators, by cells recruited to or present at the site of inflammation, modulate/influence the magnitude of the inflammatory response. A better understanding of eicosanoids and how their receptors trigger intracellular signaling during inflammatory conditions is helping to elucidate the well-known connection between chronic inflammatory disease and neoplastic transformation. In the current review, we summarize the role of LTs and PGs in chronic inflammation and, in particular, we focus on recent insights into the role of CysLT1 receptor signaling pathway. In addition, we delineate how continuous CysLT1 receptor activation and signaling can increase cell survival and proliferation as important early steps toward oncogenicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767358      PMCID: PMC5900856          DOI: 10.1100/tsw.2007.200

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  16 in total

1.  Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury.

Authors:  Jung-Sub Park; Seo-Jun Kang; Mi-Kyoung Seo; Ilo Jou; Hyun Goo Woo; Sang Myun Park
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

2.  Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132.

Authors:  Jamie L Lahvic; Michelle Ammerman; Pulin Li; Megan C Blair; Emma R Stillman; Eva M Fast; Anne L Robertson; Constantina Christodoulou; Julie R Perlin; Song Yang; Nan Chiang; Paul C Norris; Madeleine L Daily; Shelby E Redfield; Iris T Chan; Mona Chatrizeh; Michael E Chase; Olivia Weis; Yi Zhou; Charles N Serhan; Leonard I Zon
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-23       Impact factor: 11.205

3.  Protein kinase C-mediated phosphorylation of RKIP regulates inhibition of Na-alanine cotransport by leukotriene D(4) in intestinal epithelial cells.

Authors:  Subha Arthur; Uma Sundaram
Journal:  Am J Physiol Cell Physiol       Date:  2014-09-17       Impact factor: 4.249

4.  asb11 is a regulator of embryonic and adult regenerative myogenesis.

Authors:  Jin-Ming Tee; Maria A Sartori da Silva; Agnieszka M Rygiel; Vanesa Muncan; Robert Bink; Gijs R van den Brink; Paula van Tijn; Danica Zivkovic; Liudmila L Kodach; Daniele Guardavaccaro; Sander H Diks; Maikel P Peppelenbosch
Journal:  Stem Cells Dev       Date:  2012-06-07       Impact factor: 3.272

5.  Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia.

Authors:  Alec W Stranahan; Iryna Berezniuk; Sohini Chakraborty; Faye Feller; Mona Khalaj; Christopher Y Park
Journal:  Leukemia       Date:  2022-04-23       Impact factor: 12.883

6.  Classification of genes and putative biomarker identification using distribution metrics on expression profiles.

Authors:  Hung-Chung Huang; Daniel Jupiter; Vincent VanBuren
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

7.  Ketoprofen produces modality-specific inhibition of pain behaviors in rats after plantar incision.

Authors:  Christina M Spofford; Hazem Ashmawi; Alberto Subieta; Fatima Buevich; Arikha Moses; Max Baker; Timothy J Brennan
Journal:  Anesth Analg       Date:  2009-12       Impact factor: 5.108

8.  Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.

Authors:  James F Markworth; Luke Vella; Benjamin S Lingard; Dedreia L Tull; Thusitha W Rupasinghe; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-10-02       Impact factor: 3.619

9.  Activity of the leukotriene pathway in Barrett's metaplasia and oesophageal adenocarcinoma.

Authors:  James David Shutt; Philip Boger; James Richard Neale; Praful Patel; Anthony Peter Sampson
Journal:  Inflamm Res       Date:  2012-08-01       Impact factor: 4.575

10.  Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients.

Authors:  Ming-Ju Tsai; Ping-Hsun Wu; Chau-Chyun Sheu; Ya-Ling Hsu; Wei-An Chang; Jen-Yu Hung; Chih-Jen Yang; Yi-Hsin Yang; Po-Lin Kuo; Ming-Shyan Huang
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.